Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DHARMESH S PATEL

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1689651036
CMS profile
30326
Location
SOUTHAVEN, MS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$180,866.49

247 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 5 of 5; records 201–247 of 247 matching records. This page contains 47 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DHARMESH S PATEL

NPI 1689651036 · CMS profile ID 30326

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

SOUTHAVEN, MS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 5 of 5; records 201–247 of 247 matching records. This page contains 47 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1689651036?year=2021&recipient=provider&page=5#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DHARMESH S PATEL, NPI 1689651036, CMS profile ID 30326. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 5; records 201–247 of 247 matching records. This page contains 47 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1689651036?year=2021&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). DHARMESH S PATEL, NPI 1689651036, CMS profile ID 30326. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 5; records 201–247 of 247 matching records. This page contains 47 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1689651036?year=2021&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
DHARMESH S PATEL, NPI 1689651036, CMS profile ID 30326, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 5 of 5; records 201–247 of 247 matching records. This page contains 47 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1689651036?year=2021&recipient=provider&page=5#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

247 matching records · $180,866.49 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 247 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 201–247 of 247.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $1,850.0005/12/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829902781 CMS
ARBOR PHARMACEUTICALS, INC. $12.1905/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830928833 CMS
Amgen Inc. $16.8905/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825272085 CMS
AstraZeneca Pharmaceuticals LP $100.7305/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829399285 CMS
AstraZeneca Pharmaceuticals LP $11.2005/06/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829956367 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $950.0005/04/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763596612 CMS
Janssen Pharmaceuticals, Inc $1,160.0005/03/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788564881 CMS
Amgen Inc. $2,750.0004/30/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825272101 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.3404/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763596608 CMS
Janssen Pharmaceuticals, Inc $1,160.0004/20/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788564875 CMS
Janssen Pharmaceuticals, Inc $18.0204/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788565011 CMS
Janssen Pharmaceuticals, Inc $1,160.0004/19/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788564877 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $950.0004/13/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763596610 CMS
Janssen Pharmaceuticals, Inc $7.0704/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788565021 CMS
AstraZeneca Pharmaceuticals LP $16.0304/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829799035 CMS
Esperion Therapeutics, Inc. $2,400.0004/07/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838370675 CMS
Esperion Therapeutics, Inc. $1,980.0004/07/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838370681 CMS
Amgen Inc. $3,300.0004/05/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825272077 CMS
Amgen Inc. $550.0004/05/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825272081 CMS
ARBOR PHARMACEUTICALS, INC. $9.4003/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830928791 CMS
Amgen Inc. $20.5703/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825272053 CMS
Janssen Pharmaceuticals, Inc $1,160.0003/31/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788564871 CMS
Janssen Pharmaceuticals, Inc $1,160.0003/31/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788564873 CMS
Esperion Therapeutics, Inc. $117.0703/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838370673 CMS
Amgen Inc. $101.9203/29/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825272073 CMS
AstraZeneca Pharmaceuticals LP $1,400.0003/29/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829872805 CMS
AstraZeneca Pharmaceuticals LP $950.0003/29/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830201933 CMS
AstraZeneca Pharmaceuticals LP $13.3503/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830012953 CMS
Amgen Inc. $110.2603/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825272069 CMS
AstraZeneca Pharmaceuticals LP $100.0003/24/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829919183 CMS
ARBOR PHARMACEUTICALS, INC. $11.4603/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830928789 CMS
Janssen Pharmaceuticals, Inc $1,160.0003/18/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788564867 CMS
Amarin Pharma Inc. $36.2103/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815091087 CMS
Amgen Inc. $11.2003/10/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825272057 CMS
Amgen Inc. $3,300.0003/09/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825272061 CMS
Janssen Pharmaceuticals, Inc $1,160.0003/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788564869 CMS
AstraZeneca Pharmaceuticals LP $37.6403/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829558099 CMS
Amgen Inc. $114.3803/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825272065 CMS
ARBOR PHARMACEUTICALS, INC. $18.5902/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830928783 CMS
ARBOR PHARMACEUTICALS, INC. $2.8702/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830928785 CMS
Janssen Pharmaceuticals, Inc $1,160.0002/22/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788564865 CMS
Esperion Therapeutics, Inc. $2,400.0002/17/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838370667 CMS
Esperion Therapeutics, Inc. $16.7502/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838370665 CMS
ARBOR PHARMACEUTICALS, INC. $8.7102/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830928787 CMS
Amgen Inc. $21.0902/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825272049 CMS
ARBOR PHARMACEUTICALS, INC. $6.9601/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830928765 CMS
Janssen Pharmaceuticals, Inc $1,160.0001/07/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788564863 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $254,352.04 397
PY2020 $174,348.46 180
PY2021 $180,866.49 247
PY2022 $185,869.06 325
PY2023 $158,223.36 295
PY2024 $259,097.44 402
PY2025 $334,198.29 426

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $58,339.69 8
PY2024 Recipient $4,144.67 1
PY2024 Principal investigator $49,478.94 7
PY2023 Principal investigator $77,872.09 6
PY2022 Principal investigator $116,482.30 7
PY2021 Principal investigator $55,202.60 6
PY2020 Principal investigator $21,712.86 11
PY2019 Principal investigator $3,660.00 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novartis Pharmaceuticals Corporation $10,815.00 09/23/2025 Non-covered Recipient Entity
STERN CARDIOVASCULAR FOUNDATION INC
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open-Label Pelacarsen in Participants With Elevated Lp(a) and Established ASCVD No dispute reported 06/30/2026 1190309518
Principal investigator 1 Novartis Pharmaceuticals Corporation $530.67 09/08/2025 Non-covered Recipient Entity
STERN CARDIOVASCULAR FOUNDATION
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open-Label Pelacarsen in Participants With Elevated Lp(a) and Established ASCVD No dispute reported 06/30/2026 1190308216
Principal investigator 1 Chiesi USA, Inc. $190.00 06/27/2025 Non-covered Recipient Entity
STERN CARDIOVASCULAR FOUNDATION INC
LOWER:LomitapideObservational Worldwide Evaluation Registry (LOWER) No dispute reported 06/30/2026 1234403686
Principal investigator 1 Novartis Pharmaceuticals Corporation $20,932.40 01/28/2025 Non-covered Recipient Entity
THE STERN CARDIOVASCULAR FOUNDATION
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With Established Cardiovascular Disease No dispute reported 06/30/2026 1190307411
Principal investigator 1 Chiesi USA, Inc. $190.00 01/17/2025 Non-covered Recipient Entity
STERN CARDIOVASCULAR FOUNDATION INC
LOWER:LomitapideObservational Worldwide Evaluation Registry (LOWER) No dispute reported 06/30/2026 1234395697
Principal investigator 1 Novartis Pharmaceuticals Corporation $4,376.53 01/17/2025 Non-covered Recipient Entity
STERN CARDIOVASCULAR FOUNDATION
A randomized double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) in US Black/African American & Hispanic patient populations with elevated Lp(a) and established atherosclerotic cardi No dispute reported 06/30/2026 1190308214
Principal investigator 1 Novartis Pharmaceuticals Corporation $13,100.09 01/15/2025 Non-covered Recipient Entity
THE STERN CARDIOVASCULAR FOUNDATION
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With Established Cardiovascular Disease No dispute reported 06/30/2026 1190303661
Principal investigator 1 Novartis Pharmaceuticals Corporation $8,205.00 01/07/2025 Non-covered Recipient Entity
THE STERN CARDIOVASCULAR FOUNDATION
A randomized double-blind, placebo-controlled, multicenter study to evaluate the efficacy, safety and tolerability of pelacarsen (TQJ230) in US Black/African American & Hispanic patient populations with elevated Lp(a) and established atherosclerotic cardi No dispute reported 06/30/2026 1190307415